ALI MOGHANI LANKARANI
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology JACKSONVILLE, FL NPI 1215079256
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology FL GENZYME CORPORATION All categories
General Payments — all program years on this page
$126,724.05
- Category: General Payments
- Program years: PY2018–2024
- Record count: 565
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,636.02 across 58 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,636.02 | 58 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $469.09 | 6 |
| Medtronic, Inc. | $351.58 | 2 |
| Olympus America Inc. | $285.11 | 5 |
| Regeneron Pharmaceuticals, Inc. | $270.76 | 2 |
| QOL Medical, LLC | $247.64 | 6 |
| ABBVIE INC. | $183.91 | 10 |
| BOSTON SCIENTIFIC CORPORATION | $159.44 | 2 |
| Regeneron Healthcare Solutions, Inc. | $116.24 | 5 |
| Olympus Corporation of the Americas | $114.14 | 2 |
| Lucid Diagnostics Inc. | $108.33 | 1 |
| Janssen Biotech, Inc. | $80.49 | 4 |
| AIMMUNE THERAPEUTICS, INC. | $79.04 | 4 |
| Lilly USA, LLC | $63.76 | 4 |
| Madrigal Pharmaceuticals | $57.58 | 2 |
| Gilead Sciences, Inc. | $17.86 | 1 |
| Alnylam Pharmaceuticals Inc. | $16.16 | 1 |
| Merck Sharp & Dohme Corporation | $14.89 | 1 |
By program year
Records — PY2024 (58)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.